Vaccine trials for hospital superbugs need a radical rethink
A history of failure should not discourage new research. What we need is a new strategy, says Isabelle Bekeredjian-Ding, Head of Microbiology at Paul-Ehrlich-Institut and member of the IMI Scientific Committee
![Image by Viacheslav Nikolaenko via Shutterstock](/sites/default/files/styles/project_teaser_image/public/uploads/images/news-events/Newsroom/young%20nurse%20changing%20bed%20by%20Viacheslav%20Nikolaenko%20via%20shutterstock.jpg?itok=23-oY38i)